Found: 27
Select item for more details and to access through your institution.
Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01069-9
- By:
- Publication type:
- Article
Characteristic vacuolization of myeloid precursors and UBA1 mutation in a woman with monosomy X.
- Published in:
- International Journal of Laboratory Hematology, 2022, v. 44, n. 1, p. 29, doi. 10.1111/ijlh.13617
- By:
- Publication type:
- Article
7q22 deletion in myeloid malignancies: be attentive to the design of the FISH probe.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Introduction pour la place de la cytogénétique dans la prise en charge des hémopathies malignes : actualisation par le Groupe francophone de cytogénétique hématologique (GFCH).
- Published in:
- Annales de Biologie Clinique, 2016, v. 74, n. 5, p. 509, doi. 10.1684/abc.2016.1150
- By:
- Publication type:
- Article
Place de la cytogénétique dans la prise en charge des leucémies aiguës myéloïdes : actualisation par le Groupe francophone de cytogénétique hématologique (GFCH).
- Published in:
- Annales de Biologie Clinique, 2016, v. 74, n. 5, p. 535, doi. 10.1684/abc.2016.1155
- By:
- Publication type:
- Article
Place de la cytogénétique dans la prise en charge des leucémies aiguës lymphoblastiques (LAL) de l'enfant et de l'adulte : actualisation par le Groupe francophone de cytogénétique hématologique (GFCH).
- Published in:
- Annales de Biologie Clinique, 2016, v. 74, n. 5, p. 547, doi. 10.1684/abc.2016.1176
- By:
- Publication type:
- Article
Clinical and biological features of B‐cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 1, p. 72, doi. 10.1111/bjh.17141
- By:
- Publication type:
- Article
The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high‐risk clonal cytopenia of unknown significance.
- Published in:
- Genes, Chromosomes & Cancer, 2023, v. 62, n. 3, p. 139, doi. 10.1002/gcc.23107
- By:
- Publication type:
- Article
Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias.
- Published in:
- Genes, Chromosomes & Cancer, 2021, v. 60, n. 10, p. 657, doi. 10.1002/gcc.22971
- By:
- Publication type:
- Article
Prenatal diagnosis of a partial trisomy 7q in two fetuses with bilateral ventriculomegaly.
- Published in:
- 2000
- By:
- Publication type:
- Case Study
Morphology, cytogenetics, and survival in myelodysplasia with del(20q) or ider(20q): a multicenter study.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 2, p. 203, doi. 10.1007/s00277-011-1286-0
- By:
- Publication type:
- Article
Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2044, doi. 10.3390/cancers12082044
- By:
- Publication type:
- Article
CD34+CD38−CD123+ Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating Agents.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1174, doi. 10.3390/cancers12051174
- By:
- Publication type:
- Article
Outcome of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse–Bordeaux DATAML Registry Study.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 773, doi. 10.3390/cancers12040773
- By:
- Publication type:
- Article
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate‐risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006‐intermediate‐risk trial
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 1, p. 111, doi. 10.1111/ejh.13626
- By:
- Publication type:
- Article
Dactinomycin in acute myeloid leukemia with NPM1 mutations.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 3, p. 302, doi. 10.1111/ejh.13438
- By:
- Publication type:
- Article
Dismal outcome of refractory or relapsing patients with myelodysplasia‐related acute myeloid leukemia partially alleviated by intensive chemotherapy.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.7003
- By:
- Publication type:
- Article
Outcome of patients aged 60‐75 years with newly diagnosed secondary acute myeloid leukemia: A single‐institution experience.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 8, p. 3846, doi. 10.1002/cam4.2020
- By:
- Publication type:
- Article
Therapy-related acute myeloid leukemia (t- AML) with poor-risk cytogenetics in two patients with persistent molecular complete remission of acute promyelocytic leukemia.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 3, p. 267, doi. 10.1111/j.1600-0609.2012.01805.x
- By:
- Publication type:
- Article
HIV<sup>+</sup> MALT lymphoma remission induced by highly active antiretroviral therapy alone.
- Published in:
- 2005
- By:
- Publication type:
- Book Review
Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine.
- Published in:
- PLoS ONE, 2020, v. 15, n. 10, p. 1, doi. 10.1371/journal.pone.0238795
- By:
- Publication type:
- Article
Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00712-7
- By:
- Publication type:
- Article
Genomic landscape of hyperleukocytic acute myeloid leukemia.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes.
- Published in:
- 2021
- By:
- Publication type:
- Letter
14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma.
- Published in:
- Genes, Chromosomes & Cancer, 2014, v. 53, n. 8, p. 657, doi. 10.1002/gcc.22176
- By:
- Publication type:
- Article
Bendamustine for relapsed blastic plasmacytoid dendritic cell leukaemia.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Impact of obesity in favorable-risk AML patients receiving intensive chemotherapy.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 2, p. 193, doi. 10.1002/ajh.24228
- By:
- Publication type:
- Article